Revance Therapeutics

Developing neuromodulators for the treatment of aesthetic and therapeutic conditions.

Launch date

2002

Employees

501-1000 people

Market cap

Net debt

-

Enterprise valuation

$636m (Public information from May 2024)

Nashville Tennessee (HQ)

http://revance.com

https://twitter.com/revancetx https://www.linkedin.com/company/revance/

View job openings

Deals in current and previous year:

HintMD